-+ 0.00%
-+ 0.00%
-+ 0.00%

BSF Enterprise Set to Obtain US Patent for Bioactive Peptide for Collagen Production

MT Newswires·09/23/2026 03:15:18
Listen to the news
03:15 AM EDT, 09/23/2026 (MT Newswires) -- BSF Enterprise (BSFA.L) received a notice of allowance from the US Patent and Trademark Office for a new patent covering the use of a bioactive peptide to boost collagen production in cells. The British tissue-engineering biotechnology company said Wednesday the patent, which will be held by the company's 3D Bio-Tissues unit, is set to boost its patent portfolio and US footprint. BSF Enterprise added that the patent will be issued after payment of the standard administrative issue fee.